Functional Assessment of Genetically Modified Infrapatellar Fat Pad Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles (EVs): Potential Implications for Inflammation/Pain Reversal in Osteoarthritis
Cells · 09.12.2025 · 14 (24) · 1952
DOI: 10.3390/cells14241952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 09.12.2025. Verfasst von Kevin Liebmann und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, UHealth Sports Medicine Institute, Miller School of Medicine, University of Miami, Miami, FL 33146, USA. Hauptthemen laut MEDLINE: Extracellular Vesicles, Mesenchymal Stem Cells, Adipose Tissue, Inflammation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Osteoarthritis (OA) is a debilitating joint disease affecting over 500 million people globally, characterized by cartilage degradation, chronic pain, and failed tissue repair. Neurogenic inflammation, driven by neuropeptides including Substance P (SP) and calcitonin gene-related peptide (CGRP), plays a key role in the pathogenesis of OA. This study explores the therapeutic potential of extracellular vesicles (EVs) derived from infrapatellar fat pad mesenchymal stem/stromal cells (IFP-MSCs) transduced with CGRP antagonist CGRP8-37 (aCGRP IFP-MSC EVs). These EVs are enriched in anti-inflammatory miRNAs and proteins, and they express neprilysin (CD10), enabling SP degradation. Herein, several LncRNAs were identified, which have been known to interact with miRNAs that affect the knee joint homeostasis. Specifically, 11 LncRNAs (ZFAS1, EMX2OS, HOTAIRM1, RPS6KA2-AS1, DANCR, LINC-ROR, GACAT1, GNAS-AS1, HAR1A, OIP5-AS1, TERC) interact with miRNAs that promote cell proliferation, prevent apoptosis, and preserve homeostasis. In vitro, aCGRP IFP-MSC EVs downregulated pro-inflammatory markers (TNF, TLR4, MAPK8) in dorsal root ganglia and promoted chondrocyte gene expression consistent with anabolism and matrix remodeling. In vivo, intra-articular EV delivery attenuated pain behaviors, preserved the cartilage structure, restored PRG4+ stem/progenitor cell localization, and trended toward reduced SP levels. Histological analysis confirmed improved collagen organization and reduced matrix degradation. These findings suggest that aCGRP IFP-MSC EVs exert multimodal effects on neuroinflammation, cartilage regeneration, and joint homeostasis. This cell-free, gene-enhanced EV therapy offers a promising disease-modifying strategy for the treatment of OA, with the potential to address both structural changes and chronic pain associated with this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, UHealth Sports Medicine Institute, Miller School of Medicine, University of Miami, Miami, FL 33146, USA.
- Diabetes Research Institute & Cell Transplant Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
- Miami Project to Cure Paralysis, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
ORCID-Profile: Stanislava Jergova, Thomas M Best, Jacqueline Sagen, Dimitrios Kouroupis
Förderung
- NIAMS NIH HHS
- NIH HHS
- National Institutes of Health
- University of Miami Team Science Funding Program
Zitieren
APA
Liebmann, K., Castillo, M., Jergova, S., Rahimi, B., Kaplan, L. D., Best, T. M., Sagen, J., & Kouroupis, D. (2025). Functional Assessment of Genetically Modified Infrapatellar Fat Pad Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles (EVs): Potential Implications for Inflammation/Pain Reversal in Osteoarthritis. Cells, 14(24), 1952. https://doi.org/10.3390/cells14241952
Vancouver
Liebmann K, Castillo M, Jergova S, Rahimi B, Kaplan LD, Best TM, et al. Functional Assessment of Genetically Modified Infrapatellar Fat Pad Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles (EVs): Potential Implications for Inflammation/Pain Reversal in Osteoarthritis. Cells. 2025;14(24):1952. doi:10.3390/cells14241952
BibTeX
@article{Liebmann2025,
author = {Liebmann, Kevin and Castillo, Mario and Jergova, Stanislava and Rahimi, Behnaz and Kaplan, Lee D and Best, Thomas M and Sagen, Jacqueline and Kouroupis, Dimitrios},
title = {Functional Assessment of Genetically Modified Infrapatellar Fat Pad Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles (EVs): Potential Implications for Inflammation/Pain Reversal in Osteoarthritis},
journal = {Cells},
year = {2025},
volume = {14},
number = {24},
pages = {1952},
doi = {10.3390/cells14241952}
}
EUVIMED